Porovnať metódy
Prezrite si vybrané metódy vedľa seba; riadky, ktoré sa líšia, sú zvýraznené.
| Analýza silných strán založená na simulácii (silné stránky Monte Carlo)× | Sekvenčná analýza (skupinový sekvenčný dizajn)× | |
|---|---|---|
| Odbor | Štatistika | Štatistika |
| Rodina | Hypothesis test | Hypothesis test |
| Rok vzniku≠ | 2011 | 1977 |
| Tvorca≠ | Arnold et al. (2011); Green & MacLeod (2016) for mixed-model extension | P. C. O'Brien & T. R. Fleming; P. C. Pocock |
| Typ≠ | Simulation-based (Monte Carlo) | Sequential / adaptive hypothesis test |
| Pôvodný zdroj≠ | Arnold, B.F. et al. (2011). Simulation Methods to Estimate Design Power: An Overview for Applied Research. BMC Medical Research Methodology, 11, 94. DOI ↗ | O'Brien, P.C. & Fleming, T.R. (1979). A Multiple Testing Procedure for Clinical Trials. Biometrics, 35(3), 549–556. DOI ↗ |
| Ďalšie názvy | Monte Carlo power analysis, Monte Carlo simulation power, MC power, Simülasyon Tabanlı Güç Analizi (Monte Carlo Power) | sequential testing, group sequential design, interim analysis, Sıralı Analiz (Sequential Testing / Group Sequential Design) |
| Príbuzné≠ | 6 | 5 |
| Zhrnutie≠ | Simulation-based power analysis estimates the statistical power and required sample size of a study by repeating a full analysis pipeline thousands of times on artificially generated data. Because it relies on Monte Carlo simulation rather than closed-form equations, it is applicable to designs — mixed models, complex measurement structures, non-standard outcomes — where analytical power formulas do not exist. The approach was systematically described for applied research by Arnold et al. in 2011, and the mixed-model implementation via the SIMR package was formalised by Green and MacLeod in 2016. | Sequential analysis is a framework for conducting hypothesis tests with pre-planned interim looks at accumulating data, allowing a study to stop early for efficacy or futility while controlling the overall Type I error rate. The group sequential approach was formalised by Pocock (1977) and O'Brien and Fleming (1979), and remains the standard for confirmatory clinical trials and rigorous A/B experiments. |
| ScholarGateDátová sada ↗ |
|
|